Cover Image
市場調查報告書

肉毒桿菌中毒症:全球臨床實驗檢討

Botulism Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 320347
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
肉毒桿菌中毒症:全球臨床實驗檢討 Botulism Global Clinical Trials Review, H2, 2016
出版日期: 2016年08月24日 內容資訊: 英文 33 Pages
簡介

肉毒桿菌中毒症是由被稱作肉毒桿菌的細菌之毒素所引起,雖然並不常見但卻是相當嚴重的疾病。

本報告提供肉毒桿菌中毒症的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家

G7各國的臨床實驗:感染性疾病臨床實驗上肉毒桿菌中毒症所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:感染性疾病臨床實驗上肉毒桿菌中毒症所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 肉毒桿菌中毒症的治療藥臨床實驗之主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Emergent BioSolutions Inc.
    • DynPort Vaccine Company LLC
    • Merz Pharma GmbH & Co. KgaA
    • Medy-Tox Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • California Department of Public Health
    • Centre Hospitalier Universitaire, Amiens
    • Chinese PLA General Hospital
    • FDA Office of Orphan Products Development
    • Rajavithi Hospital foundation
    • The National Institute of Allergy and Infectious Diseases

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3661CTIDB

GlobalData's clinical trial report, "Botulism Global Clinical Trials Review, H2, 2016" provides an overview of Botulism clinical trials scenario. This report provides top line data relating to the clinical trials on Botulism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Botulism Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Botulism Therapeutics, Global, Clinical Trials by Region, 2016*
  • Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Botulism Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Botulism Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Botulism Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Botulism Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Botulism Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Botulism Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Botulism Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Botulism Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top